Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
cancer immunotherapy
4
×
clinical trials
4
×
europe blog main
4
×
europe top stories
fda
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
covid-19
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vir biotechnology
wisconsin blog main
wisconsin top stories
abbvie
amag pharmaceuticals
biogen
biotech ipos
cancer
What
bio
days
roundup
ipo
abbvie’s
acquisitions
ahead
alliance
announced
arrival
biofourmis
biotech
bristol
bucks
buy
calls
cancer
celebrate
ceo
chance
changing
collabs
color
companies
corner
covid
crispr
daniel
day
deal
forward
gilead
gilead’s
growing
hasn’t
help
holiday
hours
industry
introduce
Language
unset
Current search:
national
×
biotech
×
" cancer immunotherapy "
×
" clinical trials "
×
" europe blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More